{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T03:43:03Z","timestamp":1787197383494,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"52","license":[{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,30]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Chronic atrophic gastritis (CAG) is an important stage of precancerous lesions of gastric cancer, and also a key period of drug intervention. However, there is still a lack of drugs to maintain the treatment of CAG until the advent of moluodan.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>This study was conducted to assess the clinical efficacy of moluodan in the treatment of CAG by meta-analysis and trial sequential analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>China National Knowledge Infrastructure, China Biology Medicine, VIP, Wanfang, Embase, PubMed, the Cochrane Library, and Web of Science databases were searched, all with the time limit from database establishment to July 2022. The published randomized controlled trials of moluodan for CAG were conducted for meta-analysis and trial sequential analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>7 studies with a total sample size of 1143 cases were included. Compared to folic acid\/vitamins, moluodan alone significantly increased the effective rate of pathological detection (relative risk [<jats:italic toggle=\"yes\">RR<\/jats:italic>]\u2005=\u20051.73, 95% confidence interval [95%<jats:italic toggle=\"yes\">CI<\/jats:italic>]\u2005=\u2005[1.48,2.02], <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.00001), and moluodan in combination with folic acid\/vitamins significantly increased the effective rates of pathological detection (<jats:italic toggle=\"yes\">RR<\/jats:italic>\u2005=\u20051.37, 95%<jats:italic toggle=\"yes\">CI<\/jats:italic>\u2005=\u2005[1.23,1.52], <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.00001), gastroscopy (<jats:italic toggle=\"yes\">RR<\/jats:italic>\u2005=\u20051.37, 95%<jats:italic toggle=\"yes\">CI<\/jats:italic>\u2005=\u2005[1.18,1.60], <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.0001) and symptoms (<jats:italic toggle=\"yes\">RR<\/jats:italic>\u2005=\u20051.25, 95%<jats:italic toggle=\"yes\">CI<\/jats:italic>\u2005=\u2005[1.13,1.38], <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.0001). Harbord regression showed no publication bias (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.22). Quality of evidence evaluation demonstrated moderate quality of evidence for all indicators.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Moluodan can improve the effective rates of pathological examination, gastroscopy and symptoms in patients with CAG, and play a role in slowing down the disease progression and reducing clinical symptoms. It may be a potential drug for the treatment of CAG and has the value of further exploration.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000032303","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T13:02:50Z","timestamp":1672405370000},"page":"e32303","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Clinical efficacy of moluodan in the treatment of chronic atrophic gastritis: A protocol for systematic review and meta-analysis"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7309-5608","authenticated-orcid":false,"given":"Yunfeng","family":"Yu","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China"},{"name":"Hunan University of Chinese Medicine, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Yang","sequence":"additional","affiliation":[{"name":"Hunan University of Chinese Medicine, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Hu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Yin","sequence":"additional","affiliation":[{"name":"Hunan University of Chinese Medicine, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hunan University of Chinese Medicine, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yandong","family":"Wen","sequence":"additional","affiliation":[{"name":"Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3767-0142","authenticated-orcid":false,"given":"Zhenjie","family":"Liu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","first-page":"275","article-title":"Clinical efficacy of Weisu granule combined with Weifuchun tablet in the treatment of chronic atrophic gastritis and its effect on serum G-17, PG I and PG II levels.","volume":"14","author":"Li","year":"2022","journal-title":"Am J Transl Res"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/a-0859-1883","article-title":"Management of epithelial precancerous conditions and lesions in the stomach (maps II): European society of gastrointestinal endoscopy (ESGE), European helicobacter and microbiota study group (EHMSG), European society of pathology (ESP), and Sociedade Portuguesa de Endoscopia digestiva (SPED) guideline update.","volume":"51","author":"Pimentel-Nunes","year":"2019","journal-title":"Endoscopy"},{"key":"R3-20250504","first-page":"e2022184","article-title":"Recovery of gastric function in patients affected by chronic atrophic gastritis using l-cysteine (Acetium\u00ae): one year survey in comparison with a control group.","volume":"93","author":"Crafa","year":"2022","journal-title":"Acta Biomed"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"912331","DOI":"10.3389\/fmed.2022.912331","article-title":"Risk factors analysis and prediction model establishment of intestinal metaplasia or dysplasia in patients with chronic atrophic gastritis: a multi-center retrospective study.","volume":"9","author":"Pei","year":"2022","journal-title":"Front Med"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"e9734","DOI":"10.1097\/MD.0000000000009734","article-title":"Helicobacter pylori eradication may influence timing of endoscopic surveillance for gastric cancer in patients with gastric precancerous lesions: a retrospective study.","volume":"97","author":"Dore","year":"2018","journal-title":"Medicine (Baltim)"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.3760\/cma.j.issn.0366-6999.20132494","article-title":"Relationship of helicobacter pylori eradication with gastric cancer and gastric mucosal histological changes: a 10-year follow-up study.","volume":"127","author":"Zhou","year":"2014","journal-title":"Chin Med J (Engl)"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1186\/s13063-022-06395-6","article-title":"Efficacy and safety of Elian Granules in treating chronic atrophic gastritis: study protocol for a randomized, double-blind, placebo-controlled, multicenter clinical trial.","volume":"23","author":"Gu","year":"2022","journal-title":"Trials"},{"key":"R8-20250504","first-page":"84","article-title":"Characteristics of Helicobacter pylori infection in patients with chronic atrophic gastritis and prognosis evaluation of eradication therapy.","volume":"18","author":"Liu","year":"2020","journal-title":"J China Prescr Drug"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1002\/ijc.32610","article-title":"Helicobacter pylori infection, chronic atrophic gastritis and risk of stomach and esophagus cancer: results from the prospective population-based ESTHER cohort study.","volume":"146","author":"Hermann","year":"2020","journal-title":"Int J Cancer"},{"key":"R10-20250504","first-page":"91","article-title":"Chinese integrated guideline on clinical management of gastric precancerous conditions and lesions.","volume":"26","year":"2021","journal-title":"Chin J Gastroenterol"},{"key":"R11-20250504","first-page":"88","article-title":"Clinical efficacy of folic acid combined with morodan in the treatment of chronic atrophic gastritis.","volume":"41","author":"He","year":"2021","journal-title":"China For Med Treat"},{"key":"R12-20250504","first-page":"157","article-title":"Guidelines for clinical application of traditional Chinese medicine in the treatment of chronic gastritis (2020).","volume":"41","author":"Tang","year":"2021","journal-title":"Chin J Integr Trad West Med"},{"key":"R13-20250504","first-page":"2729","article-title":"[Effect of moluodan on gastric secretion in atrophic gastritis rats].","volume":"96","author":"Xie","year":"2016","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"R14-20250504","first-page":"21","article-title":"Effect of moluodan on epiderminal growth factor in patients with chronic atrophic gastritis and its clinical efficacy.","volume":"23","author":"Yan","year":"2015","journal-title":"Chin J Integr Trad West Med Dig"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R16-20250504","first-page":"121","article-title":"Consensus opinion on the diagnosis and treatment of chronic atrophic gastritis with integrated traditional Chinese and Western medicine (2017).","volume":"26","author":"Li","year":"2018","journal-title":"Chin J Integr Trad West Med Dig"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11655-015-2114-5","article-title":"Randomized double-blind clinical trial of moluodan () for the treatment of chronic atrophic gastritis with dysplasia.","volume":"22","author":"Tang","year":"2016","journal-title":"Chin J Integr Med"},{"key":"R18-20250504","first-page":"1717","article-title":"A comparison of the treatment to the chronic atrophic gastritis by the folic acid combined with vitamin E and by Mo Luo Dan.","volume":"27","author":"Du","year":"2015","journal-title":"Clin J Trad Chin Med"},{"key":"R19-20250504","first-page":"865","article-title":"Clinical effect of moluodan combined with folic acid on chronic atrophic gastritis with atypical hyperplasia.","volume":"33","author":"Feng","year":"2011","journal-title":"Hebei J Trad Chin Med"},{"key":"R20-20250504","first-page":"11","article-title":"Clinical observation on moluodan and vitamin B12in the treatment of chronic atrophic gastritis and dysplasia.","volume":"25","author":"Li","year":"2012","journal-title":"West J Trad Chin Med"},{"key":"R21-20250504","first-page":"44","article-title":"Clinical observation on 30 cases of chronic atrophic gastritis treated by moluodan combined with verinase.","volume":"48","author":"Zhang","year":"2016","journal-title":"New Chin Med"},{"key":"R22-20250504","first-page":"294","article-title":"Investigate of the clinical efficacy of moluodan combined with vitamin E for the treatment of chronic atrophic gastritis with low-grade intraepithelial neoplasia.","volume":"29","author":"He","year":"2017","journal-title":"Chin J Clin Gastroenterol"},{"key":"R23-20250504","first-page":"91","article-title":"Study on the effect of folic acid combined with moluodan in the treatment of chronic atrophic gastritis.","volume":"14","author":"Shi","year":"2017","journal-title":"J North Pharm"},{"key":"R24-20250504","first-page":"36","article-title":"Current situation of diagnosis & treatment for chronic atrophic gastritis and treating advantages of chinese medicine.","volume":"57","author":"Wei","year":"2016","journal-title":"J Tradit Chin Med"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.3748\/wjg.v26.i25.3650","article-title":"Chronic atrophic gastritis detection with a convolutional neural network considering stomach regions.","volume":"26","author":"Kanai","year":"2020","journal-title":"World J Gastroenterol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12876-022-02212-1","article-title":"Deep learning model can improve the diagnosis rate of endoscopic chronic atrophic gastritis: a prospective cohort study.","volume":"2","author":"Zhao","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"809822","DOI":"10.3389\/fonc.2022.809822","article-title":"Confocal laser endomicroscopy can improve the diagnosis rate and range assessment of patients with conflicting chronic atrophic gastritis results of white light endoscopic and pathological diagnosis.","volume":"12","author":"Pang","year":"2022","journal-title":"Front Oncol"},{"key":"R28-20250504","first-page":"86","article-title":"Recent research on etiology, pathogenesis and syndrome classification of chronic atrophic gastritis in TCM.","volume":"14","author":"Zhang","year":"2022","journal-title":"Clin J Chin Med"},{"key":"R29-20250504","first-page":"1","article-title":"Network meta-analysis of Chinese patent medicines combined with western medicines in the treatment of chronic atrophic gastritis.","author":"Ma","year":"2022","journal-title":"Pharmacol Clin Chin Materia Medica"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032303","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:25:30Z","timestamp":1746332730000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":29,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000032303","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,30]]}}}